BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21087210)

  • 1. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1.
    Najafov A; Sommer EM; Axten JM; Deyoung MP; Alessi DR
    Biochem J; 2011 Jan; 433(2):357-69. PubMed ID: 21087210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo role of the phosphate groove of PDK1 defined by knockin mutation.
    Collins BJ; Deak M; Murray-Tait V; Storey KG; Alessi DR
    J Cell Sci; 2005 Nov; 118(Pt 21):5023-34. PubMed ID: 16219676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells.
    Williams MR; Arthur JS; Balendran A; van der Kaay J; Poli V; Cohen P; Alessi DR
    Curr Biol; 2000 Apr; 10(8):439-48. PubMed ID: 10801415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors.
    Najafov A; Shpiro N; Alessi DR
    Biochem J; 2012 Dec; 448(2):285-95. PubMed ID: 23030823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. For a PDK1 inhibitor, the substrate matters.
    Knight ZA
    Biochem J; 2011 Jan; 433(2):e1-2. PubMed ID: 21175429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDK1 Inhibitor GSK-470 Exhibits Potent Anticancer Activity in a Pheochromocytoma PC12 Cell Tumor Model via Akt/mTOR Pathway.
    Zhang X; Zhong S
    Anticancer Agents Med Chem; 2020; 20(7):828-833. PubMed ID: 32188393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance.
    Bayascas JR; Wullschleger S; Sakamoto K; García-Martínez JM; Clacher C; Komander D; van Aalten DM; Boini KM; Lang F; Lipina C; Logie L; Sutherland C; Chudek JA; van Diepen JA; Voshol PJ; Lucocq JM; Alessi DR
    Mol Cell Biol; 2008 May; 28(10):3258-72. PubMed ID: 18347057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).
    García-Martínez JM; Moran J; Clarke RG; Gray A; Cosulich SC; Chresta CM; Alessi DR
    Biochem J; 2009 Jun; 421(1):29-42. PubMed ID: 19402821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma.
    Scortegagna M; Ruller C; Feng Y; Lazova R; Kluger H; Li JL; De SK; Rickert R; Pellecchia M; Bosenberg M; Ronai ZA
    Oncogene; 2014 Aug; 33(34):4330-9. PubMed ID: 24037523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The calcium-sensing receptor regulates protein tyrosine phosphorylation through PDK1 in boar spermatozoa.
    Macías-García B; García-Marín LJ; Bragado MJ; González-Fernández L
    Mol Reprod Dev; 2019 Jul; 86(7):751-761. PubMed ID: 31074040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophobic motif phosphorylation is not required for activation loop phosphorylation of p70 ribosomal protein S6 kinase 1 (S6K1).
    Keshwani MM; von Daake S; Newton AC; Harris TK; Taylor SS
    J Biol Chem; 2011 Jul; 286(26):23552-8. PubMed ID: 21561857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).
    Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR
    Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.
    Schulze JO; Saladino G; Busschots K; Neimanis S; Süß E; Odadzic D; Zeuzem S; Hindie V; Herbrand AK; Lisa MN; Alzari PM; Gervasio FL; Biondi RM
    Cell Chem Biol; 2016 Oct; 23(10):1193-1205. PubMed ID: 27693059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the cardiac mTOR/p70(S6K) pathway by leucine requires PDK1 and correlates with PRAS40 phosphorylation.
    Sanchez Canedo C; Demeulder B; Ginion A; Bayascas JR; Balligand JL; Alessi DR; Vanoverschelde JL; Beauloye C; Hue L; Bertrand L
    Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E761-9. PubMed ID: 20051528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1.
    Kim S; Jee K; Kim D; Koh H; Chung J
    J Biol Chem; 2001 Apr; 276(16):12864-70. PubMed ID: 11278269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1.
    Jensen CJ; Buch MB; Krag TO; Hemmings BA; Gammeltoft S; Frödin M
    J Biol Chem; 1999 Sep; 274(38):27168-76. PubMed ID: 10480933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast.
    Casamayor A; Torrance PD; Kobayashi T; Thorner J; Alessi DR
    Curr Biol; 1999 Feb; 9(4):186-97. PubMed ID: 10074427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3 kinase directly phosphorylates Akt1/2 at Ser473/474 in the insulin signal transduction pathway.
    Tsuchiya A; Kanno T; Nishizaki T
    J Endocrinol; 2014 Jan; 220(1):49-59. PubMed ID: 24169049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of 3-phosphoinositide-dependent kinase 1 (PDK1) signaling by the anti-tumorigenic and anti-proliferative agent n-alpha-tosyl-l-phenylalanyl chloromethyl ketone.
    Ballif BA; Shimamura A; Pae E; Blenis J
    J Biol Chem; 2001 Apr; 276(15):12466-75. PubMed ID: 11278584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDK1, the master regulator of AGC kinase signal transduction.
    Mora A; Komander D; van Aalten DM; Alessi DR
    Semin Cell Dev Biol; 2004 Apr; 15(2):161-70. PubMed ID: 15209375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.